- Syqe Medical, Ltd. and TerrAscend Corp. announced an exclusive distribution agreement to bring Syqe’s flagship product, the SyqeTM Inhaler, to the Canadian market.
- TerrAscend will utilize their platform to both provide high-quality guidance to patients on use of the Syqe device and educate the medical community on the benefits of medical cannabis and the Syqe treatment.
- For the first time ever, the amount of THC in the bloodstream can be accurately controlled in a consistent,
Read More
Israeli Digital Health Startups | Healthcare Innovation | News, Analysis, Insights - HIT Consultant
Israeli Startup MDClone Lands $26M to Expand Healthcare Data Sandbox
MDClone, an Israeli-based provider of the world’s first healthcare data sandbox has raised $26 million in Series B funding led by aMoon with participation from existing investors OrbiMed Israel Partners and Lightspeed Venture Partners. MDClone plans to utilize the funding to further develop its existing platform and build new products and novel approaches leveraging data across its global network, as well as accelerate sales and marketing efforts.Healthcare Data Sandbox: Explore and Discover
Read More
Geisinger Selects EarlySign to Apply AI Algorithms to Identify Patients At Risk of Lower GI Disorders
Geisinger Health System announced it is partnering with machine learning solution provider EarlySign to develop AI-based solutions to identify individuals at risk of a range of chronic and high-burden diseases. The multi-year agreement will begin by deploying EarlySign’s LGI Flag through Geisinger’s Steele Institute for Health Innovation – to identify patients at risk of lower gastrointestinal conditions – including colorectal cancer and precancerous adenomas. This partnership follows the
Read More
Syqe Medical Releases Pharmaceutical-Grade Medical Marijuana Inhaler
Syqe Selective-Dose Inhaler
Syqe Medical, an Israeli pharma-tech company, recently launched its newest administering device for cannabis in the form of a non-combustion inhaler.
The Syqe Inhaler™ is the company’s flagship product that utilizes innovative technology to administer proper doses of cannabis for medical marijuana patients in Israel. Syqe’s breakthrough drug delivery technology introduces complex respiration technique automation, electronic selective dosing, remote clinical
Read More
MaxQ AI Launches FDA Cleared, CE Approved Slice-Level Intracranial Hemorrhage Detection
MaxQ AI, an Israeli-based medical diagnostic AI company has launched the company’s new ACCIPIO Ax solution, which features SliceMap, an integrated view that guides clinicians rapidly to CT slices with suspected intracranial hemorrhage (ICH) without leaving their PACS viewer. Slice-Level Intracranial Hemorrhage DetectionACCIPIO Ax is FDA Cleared, CE Approved, and the second component of MaxQ AI’s ACCIPIO ICH Platform, the complete ICH solution for stroke and head trauma assessment. Radiology
Read More
Intermountain and MDClone Integrate to Transform Patient Data into Actionable Insights
Intermountain Healthcare, today announced it is teaming up with Israeli healthcare IT company MDClone to increase caregivers’ ability to transform patient data into information they can use to help people lead the healthiest lives possible. As part of the collaboration, MDClone will share a new approach to healthcare data access, analytics, and research with Intermountain. The new partnership will further transform its existing rich data sources into more meaningful information that will enable
Read More
Israeli Telehealth Startup TytoCare Extends Series C, Bringing Total Funds to $33.5M
TytoCare, an Israeli-based telehealth company, today announced it has extended its Series C funding to add key strategic investors, bringing the total funds raised to $33.5M. This is an extension of the oversubscribed 2018 round led by Ping An Global Voyager Fund with new investors Shenzhen Capital Group of China, Japan’s Itochu, and Sanford Health of the US.Founded in 2012, TytoCare has three telehealth products: TytoHome™ for consumers, TytoPro™ for professionals, and TytoClinic™ for remote
Read More
aMoon II Raises $600M Digital Health Fund to Invest in Mid to Late-Stage Companies
Israeli-based health tech and life sciences venture fund aMoon II has raised $600 million from investors and aims to raise up to $750 million by its close in February, Reuters reported. The fund's objective is to generate strong investment returns by partnering with promising mid-late-stage companies in Israel and in select other global centers of healthtech innovation.aMoon II Investment FocusFounded in 2018, aMoon II secured a $250 million investment commitment from Credit Suisse’s asset
Read More
EarlySense Raises $39M to Expand Contact-Free Monitoring & Analytics Solution
Israeli digital health startup, EarlySense, a contact-free continuous monitoring solutions provider, announced today that it has raised $39 million in funding from Hill-Rom and Wells Fargo Strategic Capital. The round also included participation from BlueRed Capital, Israel Innovation Fund, Argos Capital and Hotung Capital. Existing investors, Pitango Venture Capital and JK&B Venture Capital. Founded in 2004, EarlySense’s FDA-cleared and CE-approved solutions are used by healthcare
Read More
Medtronic Acquires Nutrino Health to Integrate Diabetes Capabilities with Nutritional Data
Medtronic acquires Nutrino Health to augment diabetes capabilities with Nutrino’s nutritional database and data science. Medtronic, a provider of medical technology announced it will acquire Tel Aviv-based Nutrino Health, a provider of nutrition-related data services, analytics, and technologies. For Medtronic, the acquisition is an opportunity to improve clinical outcomes for people with diabetes through the integration of Nutrino’s extensive food analysis infrastructure, nutrition science
Read More